Patch for Transdermal Drug Delivery

• US 20080274166A1
• Filed: 06/11/2006
• Published: 11/06/2008
• Est. Priority Date: 06/10/2005
• Status: Abandoned Application

• Current Assignee: Syneron Medical Limited (Syneron Incorporated)
• Original Assignee: TransPharma Medical Ltd. (Syneron Incorporated)
• Inventors: Stern, Meir, Sacks, Hagit, Levin, Galit, Arbel, Giora, Yossi, Bar El
• Application Number:
  US11/915,831
• Publication Number:
  US 20080274166A1
• Time in Patent Office: Days
• US Class Current: 424/449
• CPC Class Codes: A61F 2013/0296 for making transdermal patches (chemical processes excluded)
• CPC Class Codes: A61K 9/703 characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
• CPC Class Codes: A61K 9/7084 Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
• CPC Class Codes: A61P 43/00 Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

Apparatus is provided including a transdermal drug delivery patch product (10, 100), which includes a patch (20, 120), which includes a drug; and protective packaging, adapted to store the patch (20, 120), and to allow the drug to dry while the patch (20, 120) is stored in the protective packaging. Other embodiments are also described.

Claims

1. Apparatus comprising a transdermal drug delivery patch product, which comprises:

a patch, which comprises a drug; and

protective packaging, adapted to store the patch, and to allow the drug to dry while the patch is stored in the protective packaging.

2. The apparatus according to claim 1, wherein the protective packaging is configured to dry the drug to a moisture content of 2-3% by weight while the patch is stored in the protective packaging.

3. The apparatus according to claim 1, wherein the protective packaging is configured to dry the drug to a moisture content of 3-5% by weight while the patch is stored in the protective packaging.

4. The apparatus according to claim 1, wherein the patch is shaped so as to define:

a first portion shaped so as to define a frame that surrounds a window, and

a second portion, adjacent to the first portion, that defines a drug delivery area comprising the drug, and

wherein the patch is configured such that when the second portion is folded onto the first portion, the drug delivery area is placed through the window.

5. The apparatus according to claim 1, wherein the protective packaging comprises a package, adapted to store the patch, and wherein the package comprises a desiccant in fluid communication with the drug when the patch is stored in the package.

6. The apparatus according to claim 1, wherein the protective packaging comprises a removable protective covering applied to the patch, configured such that during storage, when the protective covering is applied to the patch, at least a portion of the protective covering is spaced away from the drug, and wherein the protective covering is shaped so as to define one or more holes therethrough.

7. The apparatus according to claim 6, wherein the protective packaging comprises a package, adapted to store the patch together with the protective covering, and comprising a desiccant in fluid communication with the drug via the holes when the patch is stored in the package.

8. The apparatus according to claim 6, wherein the protective covering comprises exactly one element.

9. The apparatus according to claim 8, wherein the element is shaped so as to define a peripheral area, and a raised central area shaped so as not to come in contact with the drag.

10. The apparatus according to claim 1, wherein the protective packaging comprises a removable protective covering applied to the patch, configured such that during storage, when the protective covering is applied to the patch, at least a portion of the protective covering is spaced away from the drag, and wherein the protective covering comprises a desiccant.

11. The apparatus according to claim 10, wherein the desiccant is disposed on a face of the protective covering that faces the patch.

12. The apparatus according to claim 10, wherein the protective covering is shaped so as to define one or more holes therethrough, and wherein the desiccant is disposed on a face of the protective covering that faces away from the patch, such that the desiccant is in fluid communication with the drag via the holes when the patch is stored in the protective packaging.

13. The apparatus according to claim 6, wherein the protective covering is shaped so as to define between 1 and 10 holes therethrough.

14. The apparatus according to claim 6, wherein the protective covering is shaped so as to define between 10 and 100 holes therethrough.

15. The apparatus according to claim 6, wherein the protective covering is shaped so as to define greater than 100 holes therethrough.

16. The apparatus according to claim 6, wherein the protective covering comprises at least one item selected from the list consisting of:

a cloth, a plastic, a screen, a mesh, a porous material, and a moisture-permeable film, and wherein the one or more holes are holes in the selected item.

17. A method for manufacturing a transdermal drag delivery patch product, the method comprising:

applying a drag to a patch; and

while at least a portion of the drug has greater than 6% moisture content by weight, storing the patch in protective packaging adapted to dry the drug while the patch is stored in the protective packaging.

18. The method according to claim 17, wherein storing the patch in the protective packaging comprises placing a desiccant in the protective packaging.

19. The method according to claim 17, wherein storing the patch comprises storing the patch in the protective packaging, the protective packaging being adapted to dry the drug to a moisture content of 2-3% by weight while the patch is stored in the protective packaging.

20. The method according to claim 17, wherein storing the patch comprises storing the patch in the protective packaging, the protective packaging being adapted to dry the drug to a moisture content of 3-5% by weight while the patch is stored in the protective packaging.

21. The method according to claim 17, wherein the protective packaging includes a package which includes a desiccant, and wherein storing the patch comprises storing the patch in the package such that the desiccant is in fluid communication with the drug.

22. The method according to claim 17, wherein the protective packaging includes a removable protective covering shaped so as to define one or more holes therethrough, and wherein storing the patch comprises applying the protective covering to the patch such that at least a portion of the protective covering is spaced away from the drug.

23. The method according to claim 22, wherein the protective packaging includes a package which includes a desiccant, and wherein storing the patch comprises storing the patch in the package together with the protective covering such that the desiccant is in fluid communication with the drug via the holes.

24. The method according to claim 17, wherein the protective packaging includes a removable protective covering including a desiccant, and wherein storing the patch comprises applying the protective covering to the patch such that at least a portion of the protective covering is spaced away from the drug.

25. The method according to claim 24, wherein the desiccant is disposed on a face of the protective covering that faces the patch.

26. The method according to claim 24, wherein the protective covering is shaped so as to define one or more holes therethrough, wherein the desiccant is disposed on a face of the protective covering that faces away from the patch, and wherein storing the patch comprises applying the protective covering to the patch such that the desiccant is in fluid communication with the drug via the holes.

27. A method for transdermally administering a drug to a subject, comprising:

applying a drug to a patch;

while at least a portion of the drug has greater than 6% moisture content by weight, storing the patch in protective packaging;

allowing the drug to dry while the patch is stored in the package; and

after the drug dries, applying the patch to skin of the subject, such that moisture from the skin dissolves the drug.

28. The method according to claim 27, wherein the patch is shaped so as define a first portion and a second portion adjacent to the first portion, and wherein applying the patch to the skin comprises:

adhering a frame of the first portion to the skin such that a portion of the skin is exposed through a window defined by the frame; and

folding the second portion onto the first portion, such that a drug delivery area of the second portion that comprises the drug is applied through the window to the portion of the skin.

29. The method according to claim 27, wherein storing the patch in the protective packaging comprises placing a desiccant in the protective packaging.

30. The method according to any one of claims 2729claim 27, wherein the protective packaging includes a removable protective covering shaped so as to define one or more holes therethrough, wherein storing the patch comprises applying the protective covering to the patch such that at least a portion of the protective covering is spaced away from the drug, and wherein applying the patch comprises removing the protective covering from the patch.

31. The method according to claim 30, wherein the protective packaging includes a package which includes a desiccant, and wherein storing the patch comprises storing the patch in the package together with the protective covering such that the desiccant is in fluid communication with the drug via the holes.